The ACE2 expression levels in the lung epithelial cells are lower in pediatric populations, and adult patients with COVID-19 show more robust pro-inflammatory responses or cytokine storm with worse lung lesions [23,25]. This evidence concerns the gene ACE2 and COVID-19.